FDA Releases Draft MDUFA Commitments for 2028-2032

The U.S. Food and Drug Administration has published a draft letter outlining its proposed policies and performance goals for medical device regulation under the Medical Device User Fee Act. This document details procedures for device submission, review, and clearance, along with staffing objectives for the fiscal years 2028 through 2032. A public hearing is scheduled to gather feedback on these proposed commitments.